Touted Alzheimer's disease treatment fails
Tuesday, May 7, 2013 - 12:00
in Health & Medicine
Baxter International Inc. says that a blood product it was testing failed to slow mental decline or to preserve physical function in a major study of 390 patients with mild to moderate Alzheimer's disease.